| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/12/2013 | US8394369 Chondrocyte therapeutic delivery system |
| 03/12/2013 | US8394367 IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy |
| 03/12/2013 | CA2576462C Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein |
| 03/12/2013 | CA2506724C Antibodies, polypeptides and uses thereof |
| 03/12/2013 | CA2469685C Bispecific antisense oligonucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 03/12/2013 | CA2454421C Use of long pentraxin ptx3 for treating female infertility |
| 03/12/2013 | CA2453561C Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 03/12/2013 | CA2416877C Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 03/12/2013 | CA2295552C Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 03/07/2013 | WO2013033705A2 Non-natural nucleosides as theranostic agents |
| 03/07/2013 | WO2013033657A2 CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY |
| 03/07/2013 | WO2013033407A2 Identification of small molecules that enhance therapeutic exon skipping |
| 03/07/2013 | WO2013033395A1 MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE |
| 03/07/2013 | WO2013033206A2 Compositions and methods for inhibiting ccl3 |
| 03/07/2013 | WO2013033165A2 Compositions, kits and methods for treating obesity, diabetes and hyperglycemia |
| 03/07/2013 | WO2013032943A1 Methods and compositions for the treatment of respiratory conditions via nkg2d inhibition |
| 03/07/2013 | WO2013032643A2 Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
| 03/07/2013 | WO2013032231A2 Pharmaceutical anti-angiogenic composition including a microrna-382 inhibitor |
| 03/07/2013 | WO2013032230A2 Pharmaceutical angiogenic composition including a microrna-382 activator |
| 03/07/2013 | WO2013032028A1 New compound material, medicine containing same, and cancer treatment method using same |
| 03/07/2013 | WO2013030838A2 Dendrimer-lyotropic liquid crystal (llc) systems |
| 03/07/2013 | WO2013030831A2 Pathogen and substance traps |
| 03/07/2013 | WO2013030245A1 Optical based delivery of exogenous molecules to cells |
| 03/07/2013 | WO2012156839A9 Splice - less lentiviral vectors for safter gene therapy applications |
| 03/07/2013 | WO2012148538A3 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin |
| 03/07/2013 | WO2012096545A3 Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
| 03/07/2013 | US20130061341 Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof |
| 03/07/2013 | US20130059905 Method of Gene Transfer for the Treatment of Recessive Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) |
| 03/07/2013 | US20130059904 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 03/07/2013 | US20130059777 Modulation of glucose-6-phosphatase translocase expression |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058871 Method and system for mapping synaptic connectivity using light microscopy |
| 03/06/2013 | EP2565278A1 Method for the delivery of oligonucleotides |
| 03/06/2013 | EP2565275A1 Method of treatment of vascular complications using modulators of TRX and TRXNIP |
| 03/06/2013 | EP2564870A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/06/2013 | EP2563802A1 Compositions and methods for the modification of gene transcription |
| 03/06/2013 | EP2563451A2 MEDICAL DEVICES FOR DELIVERY OF siRNA |
| 03/06/2013 | EP2563406A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 03/06/2013 | EP2563383A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| 03/06/2013 | CN102952799A Applications of gene and protein coded thereby to promotion of cell cytoplasm cleavage and cell proliferation as well as research and development of drugs |
| 03/06/2013 | CN102949733A Compound type therapeutic hepatitis B gene vaccine and construction method thereof |
| 03/06/2013 | CN102949729A Active targeting type small interfering ribonucleic acid (siRNA) delivery carrier and preparation method thereof |
| 03/06/2013 | CN102949727A Common carrier material for targeting anticancer drug and gene and preparation and application |
| 03/06/2013 | CN102274521B Graphene oxide-based target gene vector material and preparation and use thereof |
| 03/06/2013 | CN102241790B Amphipathic chitosan derivative and preparation method and application thereof |
| 03/06/2013 | CN102094042B Recombinant vector of ZNF300 gene and application thereof |
| 03/06/2013 | CN102083972B Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 03/06/2013 | CN101812127B Microtubule-associated protein and coding genes and application thereof |
| 03/06/2013 | CN101658676B Novel cell targeted medicine delivery carrier, medicine composition containing same and method for delivering medicine by same |
| 03/06/2013 | CN101522202B Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 03/05/2013 | US8389802 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 03/05/2013 | US8389709 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 03/05/2013 | US8389494 p185neu-encoding DNA and therapeutical uses thereof |
| 03/05/2013 | US8389493 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 03/05/2013 | US8389491 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
| 03/05/2013 | US8389488 Antidotes to antisense compounds |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8388975 Cancer antigen peptides derived from WT1 |
| 03/05/2013 | US8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
| 03/05/2013 | US8388945 Degradable microcapsules |
| 03/05/2013 | CA2528240C Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 02/28/2013 | WO2013027911A1 Composition for treatment or prevention of erectile dysfunction including dkk2 protein or dkk2 gene thereof and use of the composition |
| 02/28/2013 | WO2013027895A1 Composition for inhibiting angiogenesis containing a peroxidasin inhibitor as an active ingredient |
| 02/28/2013 | WO2013026334A1 Cell dna synthesis prevention and cell proliferation inhibition polypeptide and use thereof |
| 02/28/2013 | WO2012178033A3 Serpina1 sirnas: compositions of matter and methods of treatment |
| 02/28/2013 | WO2012167109A9 Rpgrip1 gene therapy for leber congenital amaurosis |
| 02/28/2013 | WO2012162342A3 Influenza vaccines containing modified adenovirus vectors |
| 02/28/2013 | WO2012159006A3 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof |
| 02/28/2013 | WO2012158910A3 Compositions and methods for treating retinal diseases |
| 02/28/2013 | WO2012145509A3 Adeno-associated-virus rep sequences, vectors, and viruses |
| 02/28/2013 | WO2012142434A3 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome |
| 02/28/2013 | WO2012128998A3 Method for delivering gene and cell therapy to a tumor or targeted site using an implanted metronomic biofeedback pump |
| 02/28/2013 | WO2012125772A3 Oral formulations for promoting cellular purification |
| 02/28/2013 | WO2012116253A3 Recombinant mumps virus vaccine |
| 02/28/2013 | WO2007025388A9 Anti-apoptotic protein antibodies |
| 02/28/2013 | US20130053431 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 02/28/2013 | US20130053428 Natural antisense and non-coding rna transcripts as drug targets |
| 02/28/2013 | US20130053426 Composition For Delivery Of Genetic Material |
| 02/28/2013 | US20130053328 Compositions and methods of inhibiting photoreceptor apoptosis |
| 02/28/2013 | US20130052737 Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/28/2013 | US20130052240 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 02/28/2013 | US20130052229 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052168 Methods and compositions for tissue regeneration |
| 02/28/2013 | US20130052159 Methods for treatment of microbial disorders |
| 02/27/2013 | EP2562257A1 Method for stabilizing functional nucleic acids |
| 02/27/2013 | EP2561887A2 Cancer therapy sensitizer |
| 02/27/2013 | EP2561078A2 NOVEL STRUCTURALLY DESIGNED shRNAs |
| 02/27/2013 | EP2561073A1 Cns targeting aav vectors and methods of use thereof |
| 02/27/2013 | CN102947451A Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1 |
| 02/27/2013 | CN102947446A Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma |
| 02/27/2013 | CN102946908A Inhibitor of expression of dominant allele |
| 02/27/2013 | CN102946907A Delivery of lentiviral vectors to the brain |
| 02/27/2013 | CN102943108A Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102942618A Telomeric protein polypeptide fragment with tumor cell killing activity and application thereof |
| 02/27/2013 | CN102940891A Lipids, lipid complexes and use thereof |
| 02/27/2013 | CN102940890A Gene application in inhibition and apoptosis of glioma cell |
| 02/27/2013 | CN102940885A Method for improving efficiency of meso-porous silicon nano materials entering into cells by utilizing cationic liposome |
| 02/27/2013 | CN102940651A Method for activation of prodrug by tumor targeting bacteria and use thereof |